These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

775 related items for PubMed ID: 18422837

  • 1. Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease.
    Lieber CS, Weiss DG, Paronetto F, Veterans Affairs Cooperative Study 391 Group.
    Alcohol Clin Exp Res; 2008 Jun; 32(6):1031-9. PubMed ID: 18422837
    [Abstract] [Full Text] [Related]

  • 2. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.
    Parés A, Deulofeu R, Giménez A, Caballería L, Bruguera M, Caballería J, Ballesta AM, Rodés J.
    Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169
    [Abstract] [Full Text] [Related]

  • 3. Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin.
    Trocme C, Leroy V, Sturm N, Hilleret MN, Bottari S, Morel F, Zarski JP.
    J Viral Hepat; 2006 Oct; 13(10):643-51. PubMed ID: 16970595
    [Abstract] [Full Text] [Related]

  • 4. Tissue inhibitor of metalloproteinase is increased in the serum of precirrhotic and cirrhotic alcoholic patients and can serve as a marker of fibrosis.
    Li J, Rosman AS, Leo MA, Nagai Y, Lieber CS.
    Hepatology; 1994 Jun; 19(6):1418-23. PubMed ID: 8188171
    [Abstract] [Full Text] [Related]

  • 5. [The relationship of serum metalloproteinase with the severity of liver fibrosis and inflammation].
    Yin SS, Li XM, Wang BE, Wang TL, Jia JD, Qian LX.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Nov; 12(11):666-8. PubMed ID: 15623375
    [Abstract] [Full Text] [Related]

  • 6. Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients.
    Zaman A, Rosen HR, Ingram K, Corless CL, Oh E, Smith K.
    Am J Med; 2007 Mar; 120(3):280.e9-14. PubMed ID: 17349453
    [Abstract] [Full Text] [Related]

  • 7. An inverse relationship between markers of fibrogenesis and collagen degradation in patients with or without alcoholic liver disease.
    Koivisto H, Hietala J, Niemelä O.
    Am J Gastroenterol; 2007 Apr; 102(4):773-9. PubMed ID: 17222322
    [Abstract] [Full Text] [Related]

  • 8. [Comparison of six potential serum markers of hepatic fibrosis in alcoholic disease of the liver].
    Grimbert S, Trinchet JC, Hartmann DJ, Munz C, Garnier M, Mal F, Callard P, Beaugrand M.
    Gastroenterol Clin Biol; 1993 Apr; 17(8-9):570-7. PubMed ID: 8253314
    [Abstract] [Full Text] [Related]

  • 9. [Screening and evaluation of non-invasive diagnosis markers for compensated liver cirrhosis in patients with chronic hepatitis B].
    Chen YP, Feng XR, Dai L, Ding HB, Zhang L.
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):225-7. PubMed ID: 12716522
    [Abstract] [Full Text] [Related]

  • 10. The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values.
    Lichtinghagen R, Pietsch D, Bantel H, Manns MP, Brand K, Bahr MJ.
    J Hepatol; 2013 Aug; 59(2):236-42. PubMed ID: 23523583
    [Abstract] [Full Text] [Related]

  • 11. [Diagnostic value of five serum markers for liver fibrosis].
    Luo R, Yang S, Xie J, Zhao Z, He Y, Yao J.
    Zhonghua Gan Zang Bing Za Zhi; 2001 Jun; 9(3):148-50. PubMed ID: 11412388
    [Abstract] [Full Text] [Related]

  • 12. Serological markers for monitoring disease progression in noncirrhotic primary biliary cirrhosis on ursodeoxycholic acid therapy.
    Färkkilä M, Rautiainen H, Kärkkäinen P, Karvonen AL, Nurmi H, Niemelä O.
    Liver Int; 2008 Jul; 28(6):787-97. PubMed ID: 18397236
    [Abstract] [Full Text] [Related]

  • 13. Non invasive prediction of severe fibrosis in patients with alcoholic liver disease.
    Tran A, Hastier P, Barjoan EM, Demuth N, Pradier C, Saint-Paul MC, Guzman-Granier E, Chevallier P, Tran C, Longo F, Schneider S, Piche T, Hebuterne X, Benzaken S, Rampal P.
    Gastroenterol Clin Biol; 2000 Jul; 24(6-7):626-30. PubMed ID: 10962384
    [Abstract] [Full Text] [Related]

  • 14. Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C.
    Patel K, Nelson DR, Rockey DC, Afdhal NH, Smith KM, Oh E, Hettinger K, Vallée M, Dev A, Smith-Riggs M, McHutchison JG.
    Clin Gastroenterol Hepatol; 2008 Feb; 6(2):242-7. PubMed ID: 18187364
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic accuracy of biomarkers measured in the hepatic vein and peripheral vein in the prediction of advanced fibrosis in patients with chronic viral hepatitis.
    Suk KT, Kim DJ, Kim CH, Park SH, Cheong JY, Cho SW, Choi JY, Han KH, Sung HT, Hong SH, Kim DY, Yoon JH, Kim YS, Baik GH, Kim JB.
    Clin Biochem; 2012 Sep; 45(13-14):1075-80. PubMed ID: 22579966
    [Abstract] [Full Text] [Related]

  • 16. Enhanced liver fibrosis panel as a predictor of liver fibrosis in chronic hepatitis C patients.
    Fernandes FF, Ferraz ML, Andrade LE, Dellavance A, Terra C, Pereira G, Pereira JL, Campos F, Figueiredo F, Perez RM.
    J Clin Gastroenterol; 2015 Mar; 49(3):235-41. PubMed ID: 24714186
    [Abstract] [Full Text] [Related]

  • 17. Cytokeratin-18 and hyaluronic acid levels predict liver fibrosis in children with non-alcoholic fatty liver disease.
    Lebensztejn DM, Wierzbicka A, Socha P, Pronicki M, Skiba E, Werpachowska I, Kaczmarski M.
    Acta Biochim Pol; 2011 Mar; 58(4):563-6. PubMed ID: 22140659
    [Abstract] [Full Text] [Related]

  • 18. [The effect of Cpd 861 on chronic hepatitis B related fibrosis and early cirrhosis: a randomized, double blind, placebo controlled clinical trial].
    Yin SS, Wang BE, Wang TL, Jia JD, Qian LX.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):467-70. PubMed ID: 15329205
    [Abstract] [Full Text] [Related]

  • 19. Serum levels of hyaluronic acid and tissue metalloproteinase inhibitor-1 combined with age predict the presence of nonalcoholic steatohepatitis in a pilot cohort of subjects with nonalcoholic fatty liver disease.
    Miele L, Forgione A, La Torre G, Vero V, Cefalo C, Racco S, Vellone VG, Vecchio FM, Gasbarrini G, Rapaccini GL, Neuman MG, Grieco A.
    Transl Res; 2009 Oct; 154(4):194-201. PubMed ID: 19766963
    [Abstract] [Full Text] [Related]

  • 20. [Serum fibrosis markers in diagnosing liver fibrosis].
    Liu J, Wang JY, Lu Y.
    Zhonghua Nei Ke Za Zhi; 2006 Jun; 45(6):475-7. PubMed ID: 16831325
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.